Your SlideShare is downloading. ×
Biotechnology
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Biotechnology

1,044
views

Published on

Published in: Technology

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,044
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
71
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Biotechnology Raj Mutharasan Dept of Chemical Engineering Drexel University
  • 2. Products of Biotechnology
  • 3. Applications Agriculture Plant breeding to improve resistance to pests, diseases, drought and salt conditions Mass propagation of plant clones Bioinsecticide development modification of plants to improve nutritional and processing characteristics Chemical Industry Production of bulk chemicals and solvents such as ethanol, citric acid, acetone and butanol Synthesis of fine specialty chemicals such as enzymes, amino acids, alkaloids and antibiotics Medicine Development of novel therapeutic molecules for medical treatments Diagnostics Drug delivery systems Tissue engineering of replacement organs Gene therapy
  • 4. Applications II Food Industry Production of bakers' yeast, cheese, yogurt and fermented foods such as vinegar and soy sauce Brewing and wine making Production of flavors and coloring agents Veterinary Practice Vaccine production Fertility control Livestock breeding Environment Biological recovery of heavy metals from mine tailings and other industrial sources Bioremediation of soil and water polluted with toxic chemicals Sewage and other organic waste treatment
  • 5. History – Early Developments 1953 Watson and Crick determined DNA structure 1970 First restriction endonuclease isolated 1973 Boyer and Cohen establish recombinant DNA methodology 1975 Kohler and Milstein describe production of monoclonal antibodies 1978 Genentech produced human insulin in E. Coli 1978 John Baxter reported cloning the gene for human growth hormone 1980 Kary Mullis(Cetus Corp.) conducted in vitro, the polymerase chain reaction (PCR). 1981 Genentech, Inc. cloned interferon gamma. Bill Rutter and Pablo Valenzuela identify hepatitis B surface antigen. Scientists at Ohio University produced the first transgenic animal. 1983 Syntex received FDA approval for a monoclonal antibody based diagnostic test for Chlamydia trachomatis. 1984 Chiron Corp. announced the first cloning and sequencing of the entire human immunodeficiency virus (HIV) genome
  • 6. History – Middle Developments 1986 Orthoclone OKT3® (Muromonab CD3) approved for reversal of acute kidney transplant rejection. Automated DNA fluorescence sequencer invented. First recombinant vaccine (for hepatitis) to Chiron Corp approved. First genetically engineered crop, gene altered tobacco plant approved. 1987 Genentech received FDA approval to market rtPA (genetically engineered tissue plasminogen activator) to treat heart attacks. Recombivax HB® (recombinant hepatitis B vaccine) approved. 1989 Epogen® (Epoetin alfa) a genetically engineered protein introduced. 1990 Approval for human somatic cell gene therapy trial. GenPharm International, Inc. created the first transgenic dairy cow. The Human Genome Project launched. Estimated cost: $13 billion. 1993 Chiron's Betaseron is approved for multiple sclerosis. Researchers clone human embryos and successfully nurture them in a Petri dish for several days. 1994 The BRCA1 gene reported to cause of non-inherited breast cancers. Vpr, a gene governing reproduction of the HIV virus.
  • 7. History – Recent Developments 1994 The enzyme telomerase reported as responsible for the unchecked growth of cells seen in human cancers. 1995 Gene therapy, immune system modulation and genetically engineered antibodies enter clinical trials. 1996 Biogen's recombinant interferon drug. Avonex® approved for multiple sclerosis. 1997 Researchers at Roslin Institute report cloning a sheep named Dolly from the cell of an adult ewe. Polly the first sheep cloned by nuclear transfer technology bearing a human gene appears later. A new DNA technique combines PCR , DNA chips, and computer programming providing a a new tool in the search for disease causing genes. 1998 Favorable results with a new antibody therapy against breast cancer, HER2neu (Herceptin), herald a new era of treatment based on molecular targeting of tumor cells. 2000 A near complete draft of the human genome map is produced, showing the locations of more than 30,000 genes.
  • 8. An Overview
  • 9. Market Values Organic molecules, $5 - $10 / g Biopolymers, $1 - $5 / g Food & beverage additives, < $1 / g Biopharmaceuticals, > $20,000 / g 5 mg hGH = $100 $100 / 0.005 g = $20,000 / g (bulk diamonds = $10,000 / g)
  • 10. Early Success Cloning the human insulin gene (story) Cloned by Genentech scientists in 1978 Licensed to Eli Lilly (why?) First recombinant drug marketed, 1982 Product revenues from human insulin (humulin) reached $839 million in 1996 (will exceed $1 billion for 1999)
  • 11. Cloning Challenges Heterologous gene expression mRNA processing Codon usage Protein folding Post-translational modifications Inclusion bodies
  • 12. Regulatory Challenges Manufacturing reproducibility Proof of product identity Proof of product purity Proof of product activity Creation of CBER in FDA
  • 13. Business Challenges Protection of proprietary technology (genetic material and manufacturing) Large-scale cGMP manufacturing Development timelines (7 - 10 years) Cost of development ($300 - $500 mill) Clinical trials
  • 14. Industry Summary - 1999 No of companies - 1300 Employees – 155,000 Market Capitalization - $ 100 b Sales = $13 b Revenue = $18 b R&D = 10b Net Loss = 5 b Human therapeutics = 75% Medical diagnostics = 18%
  • 15. Jobs in Biotechnology Bioinformatics Combinatorial chemistry Corporate development cGMP and validation Large-scale cell culture Process engineering and scale-up development Protein purification and downstream processing Regulatory affairs
  • 16. Structure of Bacteria Live cell pics at : http://www.cellsalive.com/
  • 17. Bacteria – SEM view With permission from: http://www.uq.edu.au/nanoworld/
  • 18. Structure of an Animal Cell Source: http://www.biosci.uga.edu/almanac/bio_103/notes/may_15.html.
  • 19. Biochemicals of Life
  • 20. Pairing of Nucleotides
  • 21. Central Dogma DNA makes RNA makes Protein Fig 1 Single Strand of DNA
  • 22. Genetic Code
  • 23. Essential Cloning Steps
  • 24. Essential Cloning Steps Insert the DNA into plasmids. Gene of interest is inserted into small DNA molecules known as plasmids, which are self-replicating, extrachromosomal genetic elements originally isolated from the bacterium, Escherichia coli. The circular plasmid DNA is opened using the same endonuclease that was used to cleave the genomic DNA. Join the ends of DNA with the enzyme, DNA ligase. The inserted DNA is joined to the plasmid DNA using another enzyme, DNA ligase, to give a recombinant DNA molecule. The new plasmid vector contains the original genetic information for replication of the plasmid in a host cell plus the inserted DNA.   Introduce the new vector into host. The new vector is inserted back into a host where many copies of the genetic sequence are made as the cell grows and divide with the replicating vector inside.   Isolate the newly-synthesized DNA, or the protein coded for by the inserted gene. The host may even transcribe and translate the gene and obligingly produce product of the inserted gene. Alternatively, many copies of the DNA gene itself may be isolated for sequencing the nucleic acid or for other biochemical studies.
  • 25. Amino Acids – Back bone of Proteins
  • 26. Amino Acids – II
  • 27. Process Overview Pr od u ction Fer m en tor Ster ilize Fer m en tor & Med iu m Seed Fer m en tor Stock Cu ltu r e >> Sh ak e Flask s Cell Sep ar ation Pr od u ct Pu r ification
  • 28. What are cells made of? C 50 O 20 N 14 H 8 P 3 S 1 K 1 Na 1 Ca 0.5 Mg 0.5 Cl 0.5 Fe 0.2 Element % DW others 0.3 A Good Approximation – “Formula for Cell” 2.05.08.1 NOCH
  • 29. Concept : Growth Reaction Growth Can be represented by: Considering primary constituents: In general:
  • 30. Concept : Cell Yield Glucose, mM 0 50 100 150 200 250 300 0 10 20 30 40 Slope = 7.2 µg/ml per mM Experimental observation – Cell mass is proportional to available substrate
  • 31. Cell Yield – Formal Definition Similarly, product yield is defined as: dS dX Y s/x = Cell Yield is: ConsumedSubstrate MassCellinChange Y s/x = dS dP Y S/P =
  • 32. Cell Growth in Batch Culture
  • 33. Cell Growth - Kinetics During log phase, growth kinetics is expressed as: t 0 eXX µ = µ == )2ln( tTimeDoubling d
  • 34. Typical Growth Rates Growth Rate Doubling time µ [h-1] [h] E. coli 2 0.35 Yeast 0.3 2.3 Hybridoma 0.05 13.9 Insect Cells 0.06 11.6 Organism
  • 35. Nature of Specific Growth SK S s m + µ =µ S, g/ L µ,1/h 0 0.1 0.2 0.3 0.4 0.5 0 5 10 15 20 25 Monod Kinetics Monod Kinetics. Dependence of Growth Rate on Limiting Substrate. Specific growth rate reaches a maximum value of 0.5 h-1. Value of KS here is 0.5 g L-1 . Note that when S = 0.5 g L-1, µ is half of its maximum. How does one experimentally determine cell parameters? Population Growth Rate?
  • 36. Metabolic Quotients 1 g S + YO2/S g of O2 + YNH3/S g of NH3 = YX/S g o YNH3/S g of NH3 = YX/S g of Biomass + YCO2/S CO2 + others s/2O 2O s/x xs Y r Y r 1 r − == −
  • 37. Metabolic Quotients - II General Definition: Organism qglucose qO2 g/(g h) g/(g h) E. coli 2.5 0.3 Yeast 0.5 0.2 Hybridoma 0.2 0.02 What is your “food” metabolic quotient?
  • 38. Factors Affecting Growth Rate - Temperature 0.1 1 GrowthRate 3.1 3.15 3.2 3.25 3.3 3.35 3.4 3.45 3.5 3.55 1,000/T(K) 47 Ο 45 42 39 37 30 21 17 13.5 o o o o o o o o 48 o0.5 2 3 h-1 Temperature range of life?
  • 39. Factors Affecting Growth Rate - pH 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 1.1DimentionlessSpecificGrowthRate 2 4 6 8 10 pH With Adaptation Without Adaptation µ/µm Class discussion on adaptation
  • 40. Factors Affecting Growth Rate - DO How does discharge affects DO in rivers? 0.7 0.75 0.8 0.85 0.9 0.95 1 DimensionlessGrowthRate 0 0.1 0.2 0.3 0.4 D.O (mg/l) o o o o o o o o o o o o E-Coliµ/µm Fish ?
  • 41. Growth Associated Product Formation Time PRODUCT, P CELL, X CellorProductConcentration Product expression occurs as a consequence of growth. Product formation is linked to energy metabolism. Example: alcohol fermentation. Ethanol is produced as cell metabolizes substrate sugar to derive energy, and ethanol is a byproduct of metbolism
  • 42. Non-Growth Associated Product Formation Time CELL, X PRODUCT, P CellorProductConcentration Product expression occurs as a product of secondary metbolism, and is not linked to energy metabolism. Example: Monoclonal Antibody expression by hybridoma.
  • 43. Oxygen Transfer in Bioreactors Volumetric oxygen transfer rate in a sparged bioreactor is: O2 transfered from Gas Phase - O2 consumed by Cells = Accumulation Oxygen balance over reactor:
  • 44. Oxygen Transfer in Bioreactors-II Oxygen Transfer Dynamics If supply of oxygen is balanced exactly by metabolic oxygen demand, then How does one measure oxygen transfer coeff.?
  • 45. Oxygen Transfer Coefficient When cells are absent: If supply of oxygen is shut off, then CL time O2 on O2 OffSolution:
  • 46. A Design Example You are part of a tech service team asked to evaluate if the available 10,000 liter fermentor is adequate to produce 10 kg/day of a recombinant protein using a strain of E. coli that expresses the protein as 20 % of cellular protein. In order to enhance plasmid stability, the nutrients are manipulated to give a low specific growth rate is 0.2 h-1 . The oxygen demand is 0.15 g O2/g cell - h. Assume that the recombinant protein formation is cell growth associated. Data: The lag phase is 4 hours. Typical clean-up time following a fermentation batch and preparation for the next batch is 8 hours. The plant runs three shifts. Cell yield on substrate is 0.55 g cell/g substrate. Available support services can supply inoculum of a maximum of 6 kg of cells every 24 hour period. Maximum KLa for the available fermentor is 500 h-1 . Fermentor accessories are capable of handling cell concentrations of 60 g/L. Assume any other parameters you need to complete the calculation. Class discussion of solution
  • 47. Biotechnology – The next steps This module gives a basic introduction to principles of biotechnology and biochemical engineering. With bit more background in biology, you can pursue further reading in gene therapy, human genomics, tissue engineering, cancer diagnostic tools, use of biotechnology in crime detection, and a whole score of other applications.